key: cord-0951839-1giexj8z
authors: Yasui, Fumihiko; Matsumoto, Yusuke; Yamamoto, Naoki; Sanada, Takahiro; Honda, Tomoko; Munakata, Tsubasa; Itoh, Yasushi; Kohara, Michinori
title: Infection with the SARS-CoV-2 B.1.351 variant is lethal in aged BALB/c mice
date: 2022-03-09
journal: Sci Rep
DOI: 10.1038/s41598-022-08104-4
sha: 38763cd6d885d5289d1021defbfe20472de2f96c
doc_id: 951839
cord_uid: 1giexj8z

Models of animals that are susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can usefully evaluate the efficacy of vaccines and therapeutics. In this study, we demonstrate that infection with the SARS-CoV-2 B.1.351 variant (TY8-612 strain) induces bodyweight loss and inflammatory cytokine/chemokine production in wild-type laboratory mice (BALB/c and C57BL/6 J mice). Furthermore, compared to their counterparts, BALB/c mice had a higher viral load in their lungs and worse symptoms. Importantly, infecting aged BALB/c mice (older than 6 months) with the TY8-612 strain elicited a massive and sustained production of multiple pro-inflammatory cytokines/chemokines and led to universal mortality. These results indicated that the SARS-CoV-2 B.1.351 variant-infected mice exhibited symptoms ranging from mild to fatal depending on their strain and age. Our data provide insights into the pathogenesis of SARS-CoV-2 and may be useful in developing prophylactics and therapeutics.

Wild-type laboratory mice are susceptible to infection with the SARS-CoV-2 B.1.351 variant. Three of the four VOCs had the N501Y mutation in the RBD of the S protein. This mutation may confer the ability to bind to mouse ACE2, as one of the recently reported mouse-adapted mutants has an identical mutation, being the only mutation on its spike protein 17 . Thus, we investigated whether a circulating SARS-CoV-2 variant carrying the N501Y mutation on the S protein can infect wild-type laboratory mice, similar to a mouse-adapted mutant carrying the same mutation. Eight-week-old BALB/c and C57BL/6 J mice were infected intranasally with either 1 × 10 5 or 1 × 10 6 PFU of the TY8-612 strain of the B.1.351 variant of SARS-CoV-2. Body weight changes were monitored for seven days post infection (dpi) for animals infected with 1 × 10 5 PFU of the TY-612 strain and for 14 dpi for animals infected with 1 × 10 6 PFU of the TY-612 strain. As shown in Fig. 1A , both BALB/c and C57BL/6 J mice showed transient body weight loss in an infectious dose-dependent manner. For both infectious doses of the SARS-CoV-2 TY8-612 strain, body weight loss was greater in BALB/c mice than in C57BL/6 J mice. BALB/c mice infected with 1 × 10 6 PFU of TY8-612 strain exhibited obviously ruffled fur at around 4 dpi but recovered this feature with their body weight gain. We measured viral loads in the left lung lobe of the infected mice at 3, 7, and 14 dpi via reverse transcription-quantitative PCR (RT-qPCR) to detect the nucleocapsid gene of SARS-CoV-2 (Fig. 1B) . Interestingly, at 3 dpi, the viral loads in BALB/c mice infected with 1 × 10 5 PFU were the highest among all the infected groups. At 7 dpi, the viral loads in BALB/c mice were substantially higher than those in C57BL/6 J mice. The higher viral loads in BALB/c mice were maintained up to 14 dpi. Similar to the viral RNA copy number results, the infectious viral loads at 3 dpi were mostly higher in both mouse strains infected with 1 × 10 5 PFU of the TY-612 strain than in those infected with 1 × 10 6 PFU of the TY-612 strain. Infectious viruses were undetectable 7 dpi or later, except for one BALB/c mouse and one C57BL/6 J mouse infected with 1 × 10 5 PFU at 7 dpi ( Supplementary Fig. 1A) . Consistent with the viral load data, in BALB/c mice, N antigens were detected in bronchial epithelial cells, macrophages, and stromal cells in the sections of the right upper lung lobe via immunohistochemical staining at 3 and 7 dpi (Fig. 1D , left upper and left middle panels). In contrast, in C57BL/6 J mice, N antigens were detected in bronchial epithelial cells, macrophages, and alveolar epithelial cells at 3 dpi (Fig. 1D , right upper panel) but not at 7 dpi (Fig. 1D , right middle panel). The left lung lobes of the infected mice were weighed, and the ratio of the left lung lobe weight to the body weight prior to infection (day 0) was calculated (Fig. 1C) . Although there was no significant difference, the ratio was higher in BALB/c mice than in C57BL/6 J mice at 3 and 7 dpi. Dark red and brown lesions were observed on the surfaces of the right upper and left lung lobes in BALB/c mice infected with 1 × 10 6 PFU of the TY8-612 strain at 7 dpi (Fig. 1E , left middle panel, black arrowhead). In hematoxylin and eosin (H&E) staining analyses (Fig. 1F) , BALB/c mice showed more severe pneumonia than C57BL/6 J mice. At 3 dpi, larger perivascular edema in the area was observed in BALB/c mice compared to C57BL/6 J mice ( Fig. 1F : left upper and right upper panels, yellow arrowheads). In addition, a massive infiltration of macrophages was observed in the bronchi of BALB/c mice (Fig. 1F , left upper panel, light green arrowhead). At 7 dpi, thickened alveolar walls with macrophage infiltration and hemorrhage were observed in the lungs of BALB/c mice. Conversely, an accumulation of lymphocytes around blood vessels was observed in the lungs of C57BL/6 J mice, but minimal macrophage infiltration and hemorrhages were observed (Fig. 1F , right middle panel). Pneumonia in both BALB/c and C57BL/6 J mice recovered considerably at 14 dpi, although an accumulation of lymphocytes, which may have represented possibly inducible bronchus-associated lymphoid tissue, was observed (Fig. 1F, bottom  panels) . These results demonstrated that, compared to C57BL/6 J mice, BALB/c mice were more susceptible to infection with the SARS-CoV-2 B.1.351 variant.

Infection with the SARS-CoV-2 B.1.351 variant lethally affects aged BALB/c mice. Because aged BALB/c mice have showed an increased reaction severity to SARS 20,21 , we infected 20-month-old and 6-month-old BALB/c mice intranasally with 1 × 10 6 PFU of the TY8-612 strain. Mock-infected 20-month-old BALB/c mice were inoculated intranasally with the same volume of vehicle (50 μL) as a negative control. Body weight changes and survival rates were monitored at 7 dpi in 20-month-old mice and 14 dpi in 6-month-old mice ( Fig. 2A and B, respectively) . The mock-infected 20-month-old BALB/c mice did not show any body weight loss and maintained a 100% survival rate during the experimental period ( Fig. 2A and B ). In contrast, following infection with the TY8-612 strain, both ages of BALB/c mice exhibited features such as ruffled fur, a hunched back, and reduced activity. Furthermore, more than 50% of the infected aged BALB/c mice exhibited diarrhea 5 dpi or later (data not shown), indicating that the TY8-612 strain caused multi-organ damage as well as respiratory symptoms. The 20-month-old BALB/c mice showed an irreversible and rapid decrease www.nature.com/scientificreports/ in body weight. Two-thirds of the infected 20-month-old mice died by the sixth day post-infection, and the remaining one mouse appeared emaciated at 7 dpi. The infected 6-month-old BALB/c mice showed a same or greater weight loss than the infected 20-month-old mice ( Fig. 2A) . Of the twelve 6-month-old mice, four were euthanized to collect organ samples and sera at 3 dpi; only two of the remaining eight mice survived to 14 dpi, except for one that was necropsied at 7 dpi. Hence, the survival rate was 25% (Fig. 2B ). The two surviving mice did not regain weight during the experimental period. The macroscopic appearance of the lungs of the infected www.nature.com/scientificreports/ www.nature.com/scientificreports/ 6-month-old BALB/c mice at the indicated time points is shown in Fig. 2C . At 3 dpi, most of the lung lobes were already dark red in color (top panel in Fig. 2C , black arrowheads), suggesting either congestion or hemorrhages. The macroscopic discoloration of the lung lobes did not reverse, even at 14 dpi (the second and fourth panels from the top in Fig. 2C ). In the dead mice, all lung lobes were reddish black in color (third panel from the top in Fig. 2C ). Histopathological analyses demonstrated that massive perivascular edema occurred at 3 dpi, and congestion and hemorrhages occurred at 7 dpi (upper two panels in Fig. 2D ). Congestion and hemorrhages were observed throughout all lung lobes in the animals that died at 7 dpi (third panel from the top in Fig. 2D , yellow arrowheads). At 14 dpi, accumulations of lymphocytes, granulation, and thickening of the alveolar wall caused by massive infiltration of macrophages were evident (bottom panel in Fig. 2D ; light green arrowheads indicate macrophages, and the light blue arrowhead indicates the accumulation of lymphocytes). Next, we compared body weight changes, the ratio of lung weight to body weight, and pulmonary viral loads of aged BALB/c mice (6 months) with those of young BALB/c mice (8 weeks) (Fig. 2E-G) . Aged BALB/c mice showed significant body weight loss and increased lung weight compared to the young BALB/c mice. The pulmonary viral loads in aged BALB/c mice were significantly higher than those in young BALB/c mice at 3 and 7 dpi, whereas the viral loads were comparable between aged and young BALB/c mice at 14 dpi. Similarly, at 3 dpi, the infectious viral loads in the lungs of aged BALB/c mice were higher than those in the lungs of young BALB/c mice. Importantly, infectious viruses were detected in the lungs of all aged BALB/c mice at 6-8 dpi, thereby indicating that the virus can replicate in the lungs of aged animals longer than in younger specimens ( Supplementary Fig. 1B) . Consistent with the viral load data, N antigen-positive cells were observed at 3 and 7 dpi, but not at 14 dpi, even in lesions that accumulated inflammatory cells (Fig. 2H) . These results demonstrated that 6-month-old BALB/c mice are highly vulnerable to infection with the TY8-612 strain and will exhibit lethal symptoms with high virus proliferation following infection.

There was no significant difference in clinical illness between 6-month-old and 20-month-old BALB/c mice, including weight loss and lethality ( Fig. 2A and 2B ). This may indicate that 6-month-old BALB/c mice already have impaired immunological responses, which would thus increase COVID-19 reaction severity. We measured the levels of cytokines and chemokines in the lungs of young C57BL/6 J mice and young and aged BALB/c mice to identify the mediators involved in the differences in clinical illness observed between the groups. This was performed using a multiplex bead array that simultaneously detected 32 cytokines and chemokines. As shown in Fig. 3 , the cytokines and chemokines with the highest expression levels in aged BALB/c mice during the infection interval were interleukin 6 (IL-6), leukemia inhibitory factor (LIF), granulocyte-colony stimulating factor (G-CSF), monocyte chemotactic protein 1 (MCP-1)/CCL2, macrophage inflammatory protein-2 (MIP-2)/CXCL2, keratinocyte-derived chemokine (KC)/CXCL1, IL-3, granulocyte macrophage colony-stimulating factor (GM-CSF), IL-7, IL-10, and IL-12 (p70 and mature dimers consisting of p35 and p40). In contrast, the expression levels of monokines induced by interferon gamma (MIG)/CXCL9, interferon gamma-induced protein 10 (IP10)/CXCL10, and IL-13 were highest in aged BALB/c mice at 3 dpi, but these values were highest in young BALB/c mice and low in weakened aged BALB/c mice at around 7 dpi. The lower expression levels of these IFN-γ-associated chemoattractants in aged BALB/c mice compared to those in young BALB/c mice can be attributed to the inefficient recruitment of antigen-specific CD8 + T cells to the lungs 22, 23 . At 14 dpi, when the mice were recovering but still had severe pneumonia, the expression levels of these IFN-γ-associated chemoattractants increased again in aged BALB/c mice, thus suggesting that the migration and activation of macrophages and neutrophils may contribute to the critical illness in this model. Furthermore, the expression levels of IL-1β, tumor necrosis factor-alpha (TNF-α), macrophage colony-stimulating factor (M-CSF), IL-4, and IL-12 (p40), which are inducible subunits of IL-12, IL-15, IL-17, and liposaccharide-induced CXC chemokine (LIX)/CXCL5, were higher in both young and aged BALB/c mice than in C57BL/6 J mice from the early to middle phases of infection (Fig. 4) . In addition, the expression levels of all cytokines and chemokines (shown in Fig. 4) were the highest in aged BALB/c mice at 14 dpi. Thus, these cytokines and chemokines were involved in prolonged inflammation in the lungs of aged BALB/c mice. As shown in Fig. 5 , the expression levels of regulated on activation, normal T cell expressed and secreted (RANTES)/CCL5, macrophage inflammatory protein-1 alpha (MIP-1α)/CCL3, MIP-1β/CCL4, IL-1α, and IFN-γ (except for one aged BALB/c mouse in the early phase of infection) were highest in young BALB/c mice from the early to middle phases of infection. Reportedly, the responses of specific effector T cell populations generated during an acute pathogen challenge are partly controlled by several chemokines involved in chemotaxis 24, 25 . This raises the possibility that the convergence of viral elimination and the inflammatory response was delayed, as shown in Fig. 2 . The expression levels of Eotaxin/CCL11, IL-2, IL-5, IL-9, and the vascular endothelial growth factor (VEGF) were not significantly different among the three mouse groups throughout the experimental period, except that the expression levels of VEGF in aged BALB/c mice in the middle phase of infection were lower than those in young C57BL/6 J mice ( Supplementary Fig. 2) .

To extract features that would determine the symptom severity following SARS-CoV-2 infection, we performed principal analysis (PCA) for all 32 cytokines and chemokines in the lung homogenates measured in this study (Fig. 6A) . The two most significant principal components (PC1 and PC2) explained approximately 70% of the total variation in the cytokine and chemokine data. This analysis showed that the cytokine and chemokine profiles of young C57BL/6 J mice were different from those of aged BALB/c mice, and that the profiles of young BALB/c mice were between those of the other two groups. We further conducted the variable importance project (VIP) to identify the cytokines and chemokines important in distinguishing the symptom severity among the three groups (Fig. 6B) 

In this study, we obtained the following results: first, the SARS-CoV-2 B.1.351 variant infects wild-type laboratory mice, including BALB/c and C57BL/6 J mice. Second, BALB/c mice are more susceptible to infection with this variant than B6 mice, and exhibit worse symptoms, including greater body weight loss, higher viral proliferation, and higher cytokine/chemokine production (in terms of both type and quantity). Finally, and most importantly, infecting aged BALB/c mice with this variant leads to mortality. Early SARS-CoV-2 isolates cannot easily infect wild-type laboratory mice because of the insufficient affinity of the virus for the mouse ortholog of the human receptor ACE2. Therefore, several reports have been published on the establishment of mouse-adapted mutants of SARS-CoV-2 with sufficient affinity for mouse ACE2 to infect wild-type mice 15 Because these other variants can also infect wild-type mice, further studies are necessary to analyze the infectivity and pathogenicity of other variants in wild-type mice. If these N501Y variants can be used to infect wild-type mice, in addition to improving the efficiency of animal experiments, they will also enable the use of a variety of genetically modified mice. Consequently, these improvements can be used to more rapidly detail the pathological mechanisms of COVID-19, the pathological differences of each variant, and the development of therapeutics and prophylactics. In addition, the pathogenicity of VOCs in K18-hACE2 Tg mice has been reported, which is one of the most useful COVID-19 murine models. Bayarri-Olmos et al. showed that the alpha/B.1.1.7 variant of SARS-CoV-2 exhibits a significantly higher affinity for human ACE2 and causes faster disease progression and severity than an early 2020 SARS-CoV-2 isolate 27 The genetic and phenotypic differences between BALB/c mice and C57BL/6 J mice may contribute to the observed differences in their symptoms. BALB/c mice preferentially develop a Th2 immune response, whereas C57BL/6 mice are Th1-dominant 29 . Macrophages from prototypical Th1 and Th2 strains of inbred mice are classified as M-1 and M-2 phenotypes and show different immunologic responses and phagocytic capacities 30, 31 . However, M-1/M-2 phenotypes are independent of T or B lymphocytes, as these phenotypes are also observed in macrophages from C57BL/6 and BALB/c NUDE and SCID mice 30 . Alveolar macrophages (AMs) be integral in maintaining homeostasis and are considered the first line of host defense against respiratory microbes 32, 33 . Su et al. demonstrated that the phagocytic capacity of M-1 AMs from C57BL/6 mice was greater than that of M-2 AMs from BALB/c mice 31 . C57BL/6 mice can likely clear viruses from the lungs more quickly and efficiently than their counterparts, leading to diminished inflammation. Consistent with this hypothesis, at 3 and 7 dpi, the viral loads in the lungs were lower in C57BL/6 J mice than in BALB/c mice (Fig. 1B) . In contrast, BALB/c mice cleared the viruses slower, leading to a more intensive infiltration of monocytes and neutrophils and a greater inflammatory response. www.nature.com/scientificreports/ Based on several reports that aged BALB/c mice have shown an increased reaction severity to SARS-CoV infection 20, 21 , we demonstrated that BALB/c mice older than 6 months infected with SARS-CoV-2 TY8-612 strain showed rapid body weight loss and lethality of the infection. Regarding the susceptibility of aged mice to viral infections, Wong et al. found that the number of AMs essential for lung homeostasis decreases with aging, and that aging impairs the ability of AMs to limit lung damage, such as phagocytosis, during influenza virus infection 34 . Furthermore, in a study using MASCp36, a mouse-adapted SARS-CoV-2 strain described above, aged BALB/c mice succumbed to the virus infection through upregulating the transcription of a large number of cytokines and chemokines, extensive cell death, and alveolar type II epithelial (ATII) cell loss 26 . The authors also demonstrated that the ratio of ACE2 + ATII cells in uninfected aged mice was much higher than that in uninfected young mice, and that SARS-CoV-2-infected cells were more abundant in the lungs of aged mice than in young mice. Taken together, these results support the observed aged-skewed susceptibility to SARS-CoV-2.

Through analyzing cytokine and chemokine profiles in young C57BL/6 J mice and young and aged BALB/c mice following SARS-CoV-2 infection using PLS-DA and VIP scoring, we identified the cytokines and chemokines most implicated in symptom severity and show the top 15 most potent examples in Fig. 6B . The expression levels of these cytokines and chemokines were high and prolonged in aged BALB/c mice. The expression profiles of aged BALB/c mice are similar to those of patients with severe and critical COVID-19 [35] [36] [37] [38] . Among the proinflammatory mediators found elevated in infected aged BALB/c mice, many factors are associated with www.nature.com/scientificreports/ heart failure, resulting in congestion 39 . Accordingly, congestion was observed in all aged BALB/c mice after infection with the TY8-612 strain ( Fig. 2C and D) . There is a reportedly correlation between heart injury and COVID-19 severity 40 , thus suggesting that aged BALB/c mice are useful small animal models to investigate the mechanisms underlying heart injury in severe cases of COVID-19. Moreover, SARS-CoV-2 uses ACE2 as an entry receptor. ACE2 is expressed in the human vascular endothelium, respiratory epithelium, and other cell types 41 . Under physiological conditions, ACE2, via its carboxypeptidase activity, generates angiotensin fragments (Ang 1-9 and Ang 1-7) and is essential in the renin-angiotensin system (RAS), which is a critical regulator of cardiovascular homeostasis 42 . SARS-CoV-2 infection reduces ACE2 expression in lung cells 43 . Because the loss of the pulmonary ACE2 function is associated with acute lung injury, virus-induced ACE2 downregulation may be important in disease pathology. A reduction in ACE2 function following viral infection may result in RAS dysfunction, which influences blood pressure and fluid/electrolyte balance and enhances inflammation and vascular permeability in the airways. Using the SARS-CoV-2 N501Y-variant-infected aged BALB/c mouse model, the involvement of RAS in the severity of COVID-19 may be analyzed. In contrast, the downregulation of RANTES/CCL5, MIP-1α/CCL3, and MIP-1β/CCL4 from the early to middle phase of the infection as well as the downregulation of MIG/CXCL9, IP-10/CXCL10, and IL-13 in the middle phase of the infection were observed in aged BALB/c mice. This raises the possibility that activating and recruiting antigen-specific CD8 + T cells is insufficient to control SARS-CoV-2 infection in the lungs because CD4 + T cells are inadequate [22] [23] [24] [25] . This infection model will also allow us to analyze in detail the impact of antigenspecific T cell responses on the severity of COVID-19. In this study, the immune response analysis was limited to 32 cytokines and chemokines. It is possible that other mediators are involved in lethal phenotypes. Further studies using comprehensive analyses, such as proteomics and genomics, are required to identify other factors.

In conclusion, in this study, we established a COVID-19 murine model with various symptoms ranging from mild to moderate as well as critical conditions by infecting young B6 mice and young and aged BALB/c mice with the SARS-CoV-2 B.1.351 variant. The animals showed an increase in the magnitude and persistence of both viral replication and the production of cytokines/chemokines in correlation with the severity of their symptoms. These results demonstrate that wild-type mouse models infected with the SARS-CoV-2 B.1.351 variant are useful in preclinical testing of therapeutics and prophylactics. Furthermore, future studies using this model can also include detailed evaluations of immune responses and pathogenicity. Mouse study. BALB/c mice were purchased from SLC (Shizuoka, Japan), and C57BL/6 J mice were purchased from CLEA Japan, Inc. (Tokyo, Japan). The animals were given free access to food and water and were maintained on a 12 h light/12 h dark cycle. Prior to inoculation, the animals were anesthetized via intraperitoneal administration of a ketamine-xylazine mixture. The animals were inoculated intranasally with either 1 × 10 5 PFU/50 µL or 1 × 10 6 PFU/50 µL TY8-612 strain. Clinical signs were monitored for 14 dpi, and mice were euthanized at 3, 7, and 14 dpi to collect organ samples and sera. Body weight was monitored daily, and mice that lost 30% or more of their initial body weight were scored as dead and humanely euthanized. Changes in body weight were compared between young (3 dpi, n = 10, 4-7 dpi, n = 7, 8-14 dpi, n = 3) and aged (3 dpi, n = 12, 4-7 dpi, n = 4-8, 8-14 dpi, n = 2-3) BALB/c mice at their respective time points.

Lung histopathology and immunohistochemistry. The upper lobe of the right lung from each necropsied mouse was fixed in 10% neutral buffered formalin, embedded in paraffin, sectioned at a 4 μm thickness, stained with H&E, and subjected to routine histological examination. Paraffine block sections were also used to stain the nucleocapsid (N) protein of SARS-CoV-2. Antigen retrieval was performed by autoclaving the sections in 10 mM citrate buffer (pH 6.0) for 10 min, and the sections were immersed in 0.3% hydrogen peroxide in methanol at room temperature (RT) for 30 min to inactivate endogenous peroxidase. The sections were blocked with BlockAce (DS Pharma Biomedical, Osaka, Japan) for 15 min and incubated overnight at 4 °C with 2 µg/mL of rabbit anti-N protein of the SARS-CoV-2 monoclonal antibody [HL344] (GTX635679, GeneTex, Inc., CA, USA). Secondary labeling was performed through incubation at RT for 30 min with EnVision + System-HRP labeled Polymer Anti-Rabbit (K4003; Dako Denmark A/S, Glostrup, Denmark), followed by color development with ImmPACT DAB Peroxidase Substrate (SK-4150; Vector Laboratories, Burlingame, CA, USA) at RT for 10 min. Nuclear staining was performed using a hematoxylin solution. Slides were imaged using an Axio Imager A2 microscope (Carl Zeiss Inc., Oberkochen, Germany). . Viral RNA was quantified using a 1-step reverse transcription-quantitative polymerase chain reaction (RT-qPCR) as previously described 6 . Viral loads were calculated as Log 10 copies per microgram of total RNA.

Multiple cytokine expression analyses. The supernatants of lung homogenates were assayed using the Bio-plex Suspension Array System, which utilizes luminex-based technology. For this study's experiments, a mouse cytokine/chemokine magnetic bead panel (32-plex) was used according to the manufacturer's instructions (Merck KGaA, Darmstadt, Germany).

Data plotted on a linear scale are expressed as the mean ± standard deviation (SD), except for the mean ± standard error of mean (SEM) of body weight change. Data plotted on logarithmic scales are expressed as the geometric mean ± geometric SD. Inferential statistical analysis was performed using the two-tailed non-paired Student's t-test, Mann-Whitney U test, or one-way ANOVA followed by Tukey's test, as appropriate. Statistical significance was set at p < 0.05. The Prism software package (version 9.1; GraphPad www.nature.com/scientificreports/ Software) was used for all statistical analyses. Principal component analysis (PCA) and partial least squaresdiscriminant analysis (PLS-DA) were used to analyze cytokine/chemokine profiles among three different groups (young C57BL/6 J mice, young, and aged BALB/c mice). PCA plots were used to visualize if samples from different strains or aged mice following TY8-612 strain infection were separated into discrete groups within the two-dimensional principal component (PC) space. The variable importance in projection (VIP) scores indicate important features identified by PLS-DA. PCA, PLS-DA, and VIP were performed using MetaboAnalyst 5.0, which is a web-based platform for comprehensive data analysis and interpretation of metabolomics and other omics (https:// www. metab oanal yst. ca/ home. xhtml) 45 .

Into the eye of the cytokine storm. Microbiol

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers -Eight

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

Intranasal infection of ferrets with SARS-CoV-2 as a model for asymptomatic human infection

Infection and rapid transmission of SARS-CoV-2 in ferrets

A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies

Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2

SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice

A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice

Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy

Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans

Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice

CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help

CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes

Chemokines enhance immunity by guiding naïve CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction

Chemokine Signatures of Pathogen-Specific T Cells I: Effector T Cells

Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2

The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice

SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains

The immunology of susceptibility and resistance to Leishmania major in mice

M-1/M-2 macrophages and the Th1/Th2 paradigm

C57BL/6 and BALB/c bronchoalveolar macrophages respond differently to exercise

Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice

Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development

Aging impairs alveolar macrophage phagocytosis and increases influenza-induced mortality in mice

Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors

Immunopathogenesis and treatment of cytokine storm in COVID-19

Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex

An inflammatory cytokine signature predicts COVID-19 severity and survival

Circulating cytokine levels in mice with heart failure are etiology dependent

Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Angiotensin-converting enzyme 2 in lung diseases

SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

MetaboAnalyst 50: narrowing the gap between raw spectra and functional insights

All other data are available from the corresponding author on reasonable request. 

F.Y. conceived, designed, coordinated, and performed the study and contributed to data interpretation, data presentation, and manuscript writing. Y.M. performed the virus expansion and assisted with animal experiments. N.Y. performed RNA extraction from the animal lungs and RT-qPCR for quantitation of the pulmonary viral load. T.S. T.H. and T.M. assisted with animal experiments. Y.I. performed the histopathological analyses and contributed to the data presentation and manuscript preparation. M.K. contributed to data interpretation, data presentation, and manuscript preparation. All authors reviewed the manuscript.

The authors declare no competing interests.

Supplementary Information The online version contains supplementary material available at https:// doi. org/ 10. 1038/ s41598-022-08104-4.Correspondence and requests for materials should be addressed to F.Y.Reprints and permissions information is available at www.nature.com/reprints.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.